Forster Robert 13D and 13G filings for CNS Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-07-02 12:34 pm Unchanged | 2024-06-27 | 13G | CNS PHARMACEUTICALS INC C CNSP | Forster Robert | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-06-25 7:19 pm Unchanged | 2024-06-17 | 13G | CNS PHARMACEUTICALS INC C CNSP | Forster Robert | 0 0.000% | 0 (Unchanged) | Filing |